loader2
NRI

NARAYANA HRUDAYALAYA LTD SHARE PRICE TODAY

Company details

1,290.25
1,317.10
979.95
1,444.90
6M Return 8.93%
1Y Return 24.97%
Mkt Cap.(Cr) 26,437.16
Volume 242,342
Div Yield 0.31%
OI
-
OI Chg %
-
Volume 242,342

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Healthcare Facilities company Narayana Hrudayalaya announced Q1FY25 results:

Financial Highlights: 

  • Consolidated total operating revenue was Rs 13,410 million for Q1FY25 as compared to Rs 12,334 million in the corresponding period of the previous year, reflecting a growth of 8.7% YoY and 4.8% QoQ.
  • Consolidated EBITDA stood at Rs 3,274 million, reflecting a margin of 24.4% as against Rs 2,858 million in Q1FY24, translating into a growth of 14.6% YoY and 2.8% QoQ.
  • Consolidated PAT stood at Rs 2,015 million, reflecting a margin of 15.0% as compared to Rs 1,840 million in Q1FY24, translating into growth of 9.5% YoY and 5.6% QoQ.
  • India operating revenue was Rs 10,855 million for Q1FY25 as compared to Rs 9,897 million in the corresponding period of the previous year, reflecting a growth of 9.7% YoY and 4.9% QoQ.
  • Cayman operating revenue was Rs 2,674 million for Q1FY25 as compared to Rs 2,551 million in the corresponding period of the previous year, reflecting a growth of 4.8% YoY and 5.8% QoQ.

Commenting on the performance, Emmanuel Rupert, Managing Director and Group CEO, Narayana Hrudayalaya, said: “The first quarter of the new fiscal year has started with a robust performance. We are pleased to report the highest-ever revenue on a quarterly basis with profitability sustained at high levels, which is on account of improvement in realizations and increased patient footfalls. The performance improvement is supported by strong growth in business across our flagship units, other hospitals, and steady improvements in the performance of our newer hospitals. HCCI continues to deliver strong performance on both revenue and profitability for the current quarter. NHIC has delivered another strong quarter of increased patient transactions. We are confident of delivering on our expectations for the new fiscal year.

Result PDF

View Other Company Results

Narayana Hrudayalaya Ltd shares SWOT Analysis

Strengths (8)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Growth in Net Profit with increasing Profit Margin (QoQ)
  • Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Weakness (1)

  • MFs decreased their shareholding last quarter

Opportunity (1)

  • Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Threats (1)

  • Companies with growing costs YoY for long term projects

Resistance and support

R1 1,310.4
R2 1,327.2
R3 1,337.3
Pivot

1,300.33

S1 1,283.6
S2 1,273.5
S3 1,256.7
EMA SMA
1,296.2
1,267.9
1,254.2
1,216.4
1,291.3
1,256.5
1,247.1
1,255.9
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
ISHARES CORE MSCI EMERGING MARKETS ETF Block Purchase 2022-10-17 729.7 176557 BSE
ISHARES MSCI INDIA SMALL-CAP ETF Block Purchase 2022-10-17 729.7 24703 BSE
ISHARES CORE EMERGING MARKETS MAURITIUS CO Block Sell 2022-10-17 729.7 176557 BSE
Name Category Shares
SHAKUNTALA SHETTY PROMOTER 30.38%
DEVI PRASAD SHETTY PROMOTER 11.66%
AMEYA SHETTY PROMOTER 5%
ANESH SHETTY PROMOTER 5%
VARUN SHETTY PROMOTER 5%
VIREN PRASAD SHETTY PROMOTER 5%
NARAYANA HEALTH ACADEMY PRIVATE LIMITED PROMOTER 1.81%

OUR RESEARCH VIEW

Investment recommendation
Preparing for the next capex cycle…
Call Date
08 Aug 2024
Entry Price 1,222.00
Target Price 1,485.00
Duration
12 Month

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Narayana Hrudayalaya Ltd Stocks COMPARISON

Financials( in Cr) Narayana Hrudayalaya Ltd Apollo Hospitals Enterprise Ltd Max Healthcare Institute Ltd Fortis Healthcare Ltd Syngene International Ltd
Price 1,293.65 7,031.35 931.00 596.85 938.20
% Change -1.04 0.17 2.53 2.17 1.55
Mcap Cr 26,437.16 101,100.27 90,485.01 45,059.67 37,766.02
Revenue TTM Cr 5,018.25 7,273.80 5,704.20 7,175.67 3,488.60
Net Profit TTM Cr 789.62 1,010.50 1,057.64 645.22 510.00
PE TTM 33.12 97.47 83.83 68.61 78.00
1 Year Return 24.97 40.32 59.77 81.94 12.08
ROCE 25.00 15.48 14.96 9.65 13.56
ROE 31.49 13.81 13.37 7.81 12.95
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 2,884.94 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 19,496.33 55,187.18
LAST 3M 80,557.53 41,828.42
LAST 6M 186,740.44 53,284.99
LAST 12M 326,637.89 111,035.44

Narayana Hrudayalaya Ltd Information

Stock PE (TTM)
33.12
Promoter Holding
63.85%
Book Value
141.169
ROCE
25%
ROE
31.49%
Description
  • Narayana Hrudayalaya runs a chain of multi-speciality hospitals located across India. The company also operates primary care facilities, heart centres, and other healthcare facilities. The company has its headquarters in Bengaluru. Narayana Health was started by Dr Devi Shetty in 2000. As on 19 December 2022,  the company employs more than 11,000 professionals a year.

    On 19 December 2022, the market capitalisation of the company was Rs 15,434.35 crore. It reported consolidated sales of Rs 746.55 crore at the end of September 2022. The company is listed on the Bombay Stock Exchange with the code 539551 and the National Stock Exchange with the code NH.

    The promoters of Narayana Health currently hold approximately 63.85% of the company. The foreign institutional investors’ investment in the company amounts to 14.16%. Various mutual funds hold around 13.43% of the company. The total public stake in the company is approximately 8.3%. The stake of the public has grown steadily over the past year (Since September 2021).

    Dr Devi Prasad Shetty is the chairman of the company and a whole-time director, and Emmanuel Rupert is the CEO and managing director. Viren Prasad Shetty, Kiran Mazumdar Shaw, Arun Seth, Dinesh Krishnaswamy, and TS Bresenham are the other directors of the company. Deloitte, Haskins, & Sells LLP are the auditors of Narayana Health. As of December 2022, the company had around 20.4 crore shares outstanding.

    On 19 December 2022, Narayana Health’s share price on NSE was Rs 754.2 and Rs 753.3 on BSE. The share price touched a 52-week high of Rs 810.5 and a 52-week low of Rs 545.1. Its three-month return to investors was 8.64%, while its one-year return was 32.54%. The company’s total operating income grew 12.3% quarter-on-quarter during the fourth quarter of FY22.

    As of November 2022, Axis Small Cap Direct-G has invested Rs 501.1 crore in the company. Other prominent mutual funds with investments in Naryana include SBI Small Cap Direct-G, with an investment of Rs 266.8 crore, and Nippon India Pharma Direct-G, with an investment of Rs 221.4 crore in the company.

    Some of Narayana's peers include Max Healthcare, Fortis Healthcare, and Krishna Institute of Medicine.

    Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code: 07730), BSE Ltd (Member Code: 103) and Member of Multi Commodity Exchange of India Ltd.(Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Ms. Mamta Shetty, Contact number: 022-40701022, E-mail address: complianceofficer@icicisecurities.com. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Such representations are not indicative of future results. The securities quoted are exemplary and are not recommendatory. Investors should consult their financial advisers if in doubt about whether the product is suitable for them. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.

Registered Address

No 258/A Bommasandra Indl Area, Anekal Taluq, Bengaluru, Karnataka, 560099

Tel : 91-80-71222802
Email : investorrelations:narayanahealth.org
Website : http://www.narayanahealth.org
Registrar

KFin Techologies Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 539551
NSE Code : NH
Book Closure Date (Month) :
BSE Group : A
ISIN : INE410P01011

FAQ’s on Narayana Hrudayalaya Ltd Shares

You can buy Narayana Hrudayalaya Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Narayana Hrudayalaya Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Sep 16, 2024 04:10 PM the closing price of Narayana Hrudayalaya Ltd was Rs.1,293.65.

The latest PE ratio of Narayana Hrudayalaya Ltd as of Sep 16, 2024 04:10 PM is 33.12

The latest PB ratio of Narayana Hrudayalaya Ltd as of Sep 16, 2024 04:10 PM is 0.11

The 52-week high of Narayana Hrudayalaya Ltd share price is Rs. 1,444.90 while the 52-week low is Rs. 979.95

According to analyst recommendations, Narayana Hrudayalaya Ltd Share has a "Buy" rating for the long term.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Sep 16, 2024 04:10 PM, the market cap of Narayana Hrudayalaya Ltd stood at Rs. 26,437.16 Cr.

Download App

Download Our App

Play Store App Store
market app